Cargando…

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control

BACKGROUND: As more inhaled corticosteroid (ICS) devices become available, there may be pressure for health-care providers to switch patients with asthma to cheaper inhaler devices. Our objective was to evaluate impact on asthma control of inhaler device switching without an accompanying consultatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Mike, Price, David, Chrystyn, Henry, Lloyd, Andrew, Williams, Angela E, von Ziegenweidt, Julie
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636760/ https://www.ncbi.nlm.nih.gov/pubmed/19121204 http://dx.doi.org/10.1186/1471-2466-9-1

Ejemplares similares

Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
por: Price, David, et al.
Publicado: (2014)

Effectiveness of Same Versus Mixed Asthma Inhaler Devices: A Retrospective Observational Study in Primary Care
por: Price, David, et al.
Publicado: (2012)

Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
por: Kemp, Linda, et al.
Publicado: (2010)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study
por: Martin, Richard J, et al.
Publicado: (2014)

Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study
por: Azouz, Wahida, et al.
Publicado: (2015)

Inhaled corticosteroids in childhood asthma: the story continues
por: van Aalderen, Wim M. C., et al.
Publicado: (2010)

Extrafine inhaled corticosteroid therapy in the control of asthma
por: Ivancsó, István, et al.
Publicado: (2013)

The use of inhaled corticosteroids in pediatric asthma: update
por: Hossny, Elham, et al.
Publicado: (2016)

Effect of inhaled corticosteroids on systemic inflammation in asthma
por: Karthikeyan, Ramaraju, et al.
Publicado: (2014)

Asthma progression and mortality: the role of inhaled corticosteroids
por: O'Byrne, Paul, et al.
Publicado: (2019)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
por: Lee, Ye Jin, et al.
Publicado: (2023)

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
por: Price, David, et al.
Publicado: (2011)

Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS
por: Van Eickles, Daniela, et al.
Publicado: (2015)

Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
por: Vähätalo, Iida, et al.
Publicado: (2021)

Is underuse of Inhaled Corticosteroids for Asthma in India contributing to 42% of global asthma deaths?
por: Salvi, Sundeep, et al.
Publicado: (2022)

Asthma control in patients receiving inhaled corticosteroid and long-acting beta(2)-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
por: Müller, Veronika, et al.
Publicado: (2011)

Size of Inhaled Corticosteroid and Small Airway Inflammation in Asthma
por: Park, Choon-Sik
Publicado: (2017)

Inhaled Corticosteroids in Asthma: Promoting or Protecting Against Atherosclerosis?
por: Podgórski, Michał, et al.
Publicado: (2017)

Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma
por: Kim, Sang-Heon
Publicado: (2019)

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
por: Ekbom, Emil, et al.
Publicado: (2019)

Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Kachroo, Priyadarshini, et al.
Publicado: (2021)

Dynamics of inhaled corticosteroid use are associated with asthma attacks
por: Lee, Joy, et al.
Publicado: (2021)

Device errors in asthma and COPD: systematic literature review and meta-analysis
por: Chrystyn, Henry, et al.
Publicado: (2017)

297 Relationship Between Exhaled Nitric Oxide and Levels of Asthma Control in Asthma Patients Treated with Inhaled Corticosteroid
por: Yoon, Ho Joo, et al.
Publicado: (2012)

Risk Factors for Non-Adherence to Inhaled Corticosteroids in Preschool Children with Asthma
por: Bach, Louise Mandrup, et al.
Publicado: (2022)

Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
por: Schaffner, Timothy J, et al.
Publicado: (2009)

Predicting Inhaled Corticosteroid Response in Asthma with Two Associated SNPs
por: McGeachie, Michael J., et al.
Publicado: (2012)

Stepping down inhaled corticosteroid use in asthma - who is responsible?
por: Chaudhary, Ashbal, et al.
Publicado: (2015)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
por: Vasbinder, Erwin C, et al.
Publicado: (2016)

Inhaled corticosteroids may prevent lung cancer in asthma patients
por: Wang, I-Jen, et al.
Publicado: (2018)

The influence of inhaled corticosteroid discontinuation in children with well-controlled asthma
por: Zheng, Shengkun, et al.
Publicado: (2017)

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
por: Cazzola, Mario, et al.
Publicado: (2020)

12-year adherence to inhaled corticosteroids in adult-onset asthma
por: Vähätalo, Iida, et al.
Publicado: (2020)

Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
por: Adir, Yochai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p6lhf8bp34l5m1u0g74no4afta